|Bid||680.00 x 0|
|Ask||1,300.00 x 0|
|Day's range||1,040.50 - 1,051.50|
|52-week range||887.00 - 1,316.75|
|Beta (5Y monthly)||0.47|
|PE ratio (TTM)||52.45|
|Earnings date||27 Feb 2024|
|Forward dividend & yield||0.30 (2.89%)|
|Ex-dividend date||05 Oct 2023|
|1y target est||12.93|
These three dividend stocks are some of the most reliable payers in the FTSE 100 index. And they all have decent long-term growth prospects. The post If I could only buy 3 dividend stocks for my Stocks and Shares ISA, I’d pick these winners appeared first on The Motley Fool UK.
Key Insights Smith & Nephew's estimated fair value is UK£17.05 based on 2 Stage Free Cash Flow to Equity Smith...
Smith & Nephew (SNN) will pay an initial cash consideration of $180 million at closure, with an additional $150 million based on financial performance to acquire CartiHeal.